BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, Davis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Jaeb Center for Health Research
University of Giessen
University of Nebraska
OHSU Knight Cancer Institute
Thomas Jefferson University
Northwestern University
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
University of Chicago
Wake Forest University Health Sciences
The Cleveland Clinic
Fred Hutchinson Cancer Center
HaEmek Medical Center, Israel
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
University of Louisville
Vanderbilt University Medical Center
Fred Hutchinson Cancer Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
CHU de Reims
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Indiana University
Indiana University
University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
University of South Florida
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center